Insider trades
Christopher John Kenney, Chief Officer of Xenon Pharmaceuticals XENE, has filed 0 purchases and 3 sales on the open market. Over the past 12 months that comes to a net sale of $244.4K. The latest trade was on 03/13.
Christopher John Kenney
Chief Medical Officer
- Company
- Xenon Pharmaceuticals XENE
- First filing
- 23/03/14
- Trades
- 14 trades
- Buys / sales
- 0 / 3
- 12-month net buying
- −$244.4K
- Last trade
- 03/13
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 03/13 | 03/13 | 1,410 sh | $55.23 | $77,874.3 | −16.6% | |
| Open-market sale10b5-1 plan | 03/10 | 03/11 | 2,771 sh | $60.11 | $166,564.81 | −36.9% | |
| Open-market sale | 23/03/24 | 23/03/24 | 700 sh | $35.01 | $24,507 | −100.0% |